migrain. common migrain
Conditions
Interventions
Intervention 1: In the control group: oral medication nortriptyline(tablet) 25 mg once a day for a month(Made in Abidi Company). Intervention 2: In the intervention group: oral medication venlafaxine(
Treatment - Drugs
In the control group: oral medication nortriptyline(tablet) 25 mg once a day for a month(Made in Abidi Company)
In the intervention group: oral medication venlafaxine(Tablet) 37.5 mg dose twice a day for one month.(made in Abidi Company)
Sponsors
Vice Chancellor for research of Tehran Azad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with migraine that they did not receive other drugs in the past two months. Exclusion criteria: The incidence of major complications (side effects that need to cut the treatment, if they happened)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of Migraine headache. Timepoint: Before the intervention,one month after intervention. Method of measurement: Questionnaire.;Intensity of Migraine headache. Timepoint: Before the intervention,one month after intervention. Method of measurement: Questionnaire.;Duration of Migraine headache. Timepoint: Before the intervention,one month after intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNima Mohsenzadeh Kermani
Islamic Azad University Tehran Medical Branch
Outcome results
None listed